BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29398422)

  • 1. Hormone Replacement Therapy and Colorectal Cancer Incidence and Mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Symer MM; Wong NZ; Abelson JS; Milsom JW; Yeo HL
    Clin Colorectal Cancer; 2018 Jun; 17(2):e281-e288. PubMed ID: 29398422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of hormone replacement therapy on lung cancer incidence and mortality.
    Titan AL; He H; Lui N; Liou D; Berry M; Shrager JB; Backhus LM
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1546-1556.e4. PubMed ID: 31866083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy and colorectal cancer risk in elderly women.
    Paganini-Hill A
    Dis Colon Rectum; 1999 Oct; 42(10):1300-5. PubMed ID: 10528768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and colorectal cancer incidence and mortality.
    Lavasani S; Chlebowski RT; Prentice RL; Kato I; Wactawski-Wende J; Johnson KC; Young A; Rodabough R; Hubbell FA; Mahinbakht A; Simon MS
    Cancer; 2015 Sep; 121(18):3261-71. PubMed ID: 26036212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.
    Abdel-Rahman O
    Int J Clin Oncol; 2020 May; 25(5):885-891. PubMed ID: 31919692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).
    Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB
    Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.
    Jang YC; Huang HL; Leung CY
    BMC Cancer; 2019 Dec; 19(1):1199. PubMed ID: 31818262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults : BMI change and the risks of colorectal cancer incidence and mortality.
    Li JB; Luo S; Wong MCS; Li C; Feng LF; Peng JH; Li JH; Zhang X
    BMC Cancer; 2019 Nov; 19(1):1082. PubMed ID: 31711465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
    Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
    Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
    Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy in relation to survival from large bowel cancer.
    Newcomb PA; Chia VM; Hampton JM; Doria-Rose VP; Trentham Dietz A
    Cancer Causes Control; 2009 May; 20(4):409-16. PubMed ID: 18998219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.
    Grodstein F; Newcomb PA; Stampfer MJ
    Am J Med; 1999 May; 106(5):574-82. PubMed ID: 10335731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
    Nanda K; Bastian LA; Hasselblad V; Simel DL
    Obstet Gynecol; 1999 May; 93(5 Pt 2):880-8. PubMed ID: 10912438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Oken MM; Marcus PM; Hu P; Beck TM; Hocking W; Kvale PA; Cordes J; Riley TL; Winslow SD; Peace S; Levin DL; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Dec; 97(24):1832-9. PubMed ID: 16368945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women.
    Kabat GC; Miller AB; Rohan TE
    Int J Cancer; 2008 Feb; 122(3):643-6. PubMed ID: 17847020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.